# Phase I Trial Evaluating the Pharmacokinetics of Single Ascending Oral Doses of IRL757 in Healthy Elderly Volunteers

> **NCT06699628** · PHASE1 · COMPLETED · sponsor: **Integrative Research Laboratories AB** · enrollment: 12 (actual)

## Conditions studied

- Not Applicable as This is a Mass Balance/Pharmacokinetic Study Performed in Healthy Subjects
- Apathy

## Interventions

- **DRUG:** IRL757

## Key facts

- **NCT ID:** NCT06699628
- **Lead sponsor:** Integrative Research Laboratories AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-23
- **Primary completion:** 2024-11-11
- **Final completion:** 2024-11-11
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06699628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06699628, "Phase I Trial Evaluating the Pharmacokinetics of Single Ascending Oral Doses of IRL757 in Healthy Elderly Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06699628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*